A Valuable COVID Drug Doesn’t Work against New Variants
Current monoclonal antibodies fail against COVID virus variants, so drugmakers want to use a fast-track test for new ones
Current monoclonal antibodies fail against COVID virus variants, so drugmakers want to use a fast-track test for new ones
The FDA has called for updating COVID vaccines to address the Omicron subvariants BA.4 and BA.5. But will the shots keep up with the virus?
Does the new strain sweeping the globe mean COVID will become ever more contagious?
Burning piles of used gloves, test kits and syringes release toxic pollutants. But there are ways to improve medical recycling
A new study in Mexico shows that non-mRNA vaccines like the Russian version can be as effective as mRNA vaccines like Pfizer if the patient has previously been infected with SARS-CoV-2.
Vaccine makers worry yet another variant will start dominating in the months it takes to roll out shots against this one
Copyright © 2024 | WordPress Theme by MH Themes